After finishing at $13.89 in the prior trading day, Takeda Pharmaceutical Co ADR (NYSE: TAK) closed at $13.67, down -1.58%. In other words, the price has decreased by -$0.22 from its previous closing price. On the day, 1158844 shares were traded.
Ratios:
Our goal is to gain a better understanding of TAK by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 20.97 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 12.31. For the most recent quarter (mrq), Quick Ratio is recorded 0.55 and its Current Ratio is at 1.06. In the meantime, Its Debt-to-Equity ratio is 0.69 whereas as Long-Term Debt/Eq ratio is at 0.64.
On July 19, 2022, Cowen Upgraded its rating to Outperform which previously was Market Perform and also upped its target price recommendation from $21 to $24.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 24 ’24 when TAKEDA PHARMACEUTICAL CO LTD sold 3,703,703 shares for $8.10 per share. The transaction valued at 29,999,994 led to the insider holds 3,755,583 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TAK now has a Market Capitalization of 43.09B and an Enterprise Value of 71.80B. As of this moment, Takeda’s Price-to-Earnings (P/E) ratio for their current fiscal year is 34.18, and their Forward P/E ratio for the next fiscal year is 28.93. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1709.18. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.45 while its Price-to-Book (P/B) ratio in mrq is 0.90. Its current Enterprise Value per Revenue stands at 0.02 whereas that against EBITDA is 0.07.
Stock Price History:
Over the past 52 weeks, TAK has reached a high of $17.15, while it has fallen to a 52-week low of $13.19. The 50-Day Moving Average of the stock is 14.45, while the 200-Day Moving Average is calculated to be 14.75.
Shares Statistics:
The stock has traded on average 1.84M shares per day over the past 3-months and 1.67M shares per day over the last 10 days, according to various share statistics. A total of 3.14B shares are outstanding, with a floating share count of 3.14B. Insiders hold about 0.02% of the company’s shares, while institutions hold 5.45% stake in the company. Shares short for TAK as of Mar 15, 2024 were 5.5M with a Short Ratio of 3.00, compared to 7.99M on Feb 15, 2024.
Dividends & Splits
In the trailing 12 months, TAK’s forward annual dividend rate was 184.00, compared to 0.32 this year. Against a Trailing Annual Dividend Yield of 1,324.69%, it implies a Forward Annual Dividend Yield of 4.67%. The stock’s 5-year Average Dividend Yield is 4.72.
Earnings Estimates
Its stock is currently analyzed by 0 different market analysts. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0. EPS for the following year is $0, with 0 analysts recommending between $0 and $0.
